99 related articles for article (PubMed ID: 30767502)
1. Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.
Dazhi W; Jing D; Chunling R; Mi Z; Zhixuan X
Biomark Med; 2019 Feb; 13(2):95-104. PubMed ID: 30767502
[TBL] [Abstract][Full Text] [Related]
2. Elevated
Wang D; Deng L; Xu X; Ji Y; Jiao Z
Genet Test Mol Biomarkers; 2021 Mar; 25(3):236-246. PubMed ID: 33734892
[No Abstract] [Full Text] [Related]
3. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
Wang D; Jiao Z; Ji Y; Zhang S
J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
[TBL] [Abstract][Full Text] [Related]
4. High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.
Wang D; Liu H; Ren C; Wang L
Genet Test Mol Biomarkers; 2019 Feb; 23(2):91-97. PubMed ID: 30676103
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
6. High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.
Wang D; Zhang S; Chen F
Genet Test Mol Biomarkers; 2018 Jun; 22(6):366-373. PubMed ID: 29723071
[TBL] [Abstract][Full Text] [Related]
7. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
Zhao W; Wang Y; Yue X
Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
[TBL] [Abstract][Full Text] [Related]
8. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
9. Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.
Song SH; Jeon MS; Nam JW; Kang JK; Lee YJ; Kang JY; Kim HP; Han SW; Kang GH; Kim TY
Oncogene; 2018 Feb; 37(8):993-1004. PubMed ID: 29106391
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.
Tran TT; Mu A; Adachi Y; Adachi Y; Taketani S
Photochem Photobiol; 2014; 90(5):1136-43. PubMed ID: 24842606
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
13. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
14. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of thyroid hormone receptor-interacting protein 13 drives tumorigenesis and affects clinical outcome.
Dazhi W; Mengxi Z; Fufeng C; Meixing Y
Biomark Med; 2017 Jan; 11(1):19-31. PubMed ID: 27827544
[TBL] [Abstract][Full Text] [Related]
16. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
17. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
18. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
Nie F; Yu X; Huang M; Wang Y; Xie M; Ma H; Wang Z; De W; Sun M
Oncotarget; 2017 Jun; 8(24):38227-38238. PubMed ID: 27246976
[TBL] [Abstract][Full Text] [Related]
20. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
